We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Curative Cell and Gene Therapy for Osteogenesis Imperfecta.
- Authors
Schindeler, Aaron; Lee, Lucinda R; O'Donohue, Alexandra K; Ginn, Samantha L; Munns, Craig F
- Abstract
Osteogenesis imperfecta (OI) describes a series of genetic bone fragility disorders that can have a substantive impact on patient quality of life. The multidisciplinary approach to management of children and adults with OI primarily involves the administration of antiresorptive medication, allied health (physiotherapy and occupational therapy), and orthopedic surgery. However, advances in gene editing technology and gene therapy vectors bring with them the promise of gene‐targeted interventions to provide an enduring or perhaps permanent cure for OI. This review describes emergent technologies for cell‐ and gene‐targeted therapies, major hurdles to their implementation, and the prospects of their future success with a focus on bone disorders. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
- Subjects
OSTEOGENESIS imperfecta; GENE therapy; CELLULAR therapy; OCCUPATIONAL therapy; ORTHOPEDIC surgery
- Publication
Journal of Bone & Mineral Research, 2022, Vol 37, Issue 5, p826
- ISSN
0884-0431
- Publication type
Article
- DOI
10.1002/jbmr.4549